Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
72 participants
INTERVENTIONAL
2015-07-31
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
BASIC_SCIENCE
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Terbutaline
Beta2-adrenergic stimulation with terbutaline
No training
Endurance training
Resistance Training
Terbutaline
Placebo
Placebo
No training
Endurance training
Resistance Training
Placebo
Clenbuterol
Beta2-adrenergic stimulation with clenbuterol
No training
Clenbuterol
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No training
Endurance training
Resistance Training
Terbutaline
Clenbuterol
Placebo
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18-35 years of age
* Informed consent
* Active 2-5 hours of training pr. week
* Maximal oxygen uptake (ml/min/kg) of 40-60
* Lean body mass of 55-65 kg / Lean mass index 14-22 kg/m2
Exclusion Criteria
* Allergy towards study drugs
* Chronic disease
18 Years
35 Years
MALE
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Copenhagen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Morten Nielsen
Post.Doc
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Nutrition, Exercise and Sports
Copenhagen, , Denmark
Bispebjerg University Hospital
Copenhagen, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Morten Hostrup, PhD
Role: primary
Morten Hostrup, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TUD
Identifier Type: -
Identifier Source: org_study_id